Rajesh Chopra

Rajesh Chopra

Director Ejecutivo en Aethon Therapeutics, Inc. .

63 años
Health Technology
Consumer Services
Miscellaneous

Perfil

Rajesh Chopra is currently the Chief Executive Officer & Director at Aethon Therapeutics, Inc. He is also a Non-Executive Director at Artios Pharma Ltd., a Director at Nereid Therapeutics, Inc., and a Venture Partner at Apple Tree Venture Management Llc.
In the past, he worked as a Director-Medical Science at AstraZeneca PLC from 2004 to 2009, an Independent Non-Executive Director at e-Therapeutics Plc from 2012 to 2015, and as the VP-Translational & Early Drug Development at Celgene Corp.
from 2009 to 2016.
He also served as the Director-Hematological Oncology Department at The Christie NHS Foundation Trust.
Dr. Chopra holds a doctorate degree from University College London and an undergraduate degree from The UCL Academy.

Cargos activos de Rajesh Chopra

EmpresasCargoInicio
Director/Miembro de la Junta 11/02/2019
Inversor de Capital Privado 21/10/2021
Director/Miembro de la Junta -
Director Ejecutivo -
Todos los cargos activos de Rajesh Chopra

Antiguos cargos conocidos de Rajesh Chopra.

EmpresasCargoFin
CELGENE Corporate Officer/Principal 01/01/2016
E-THERAPEUTICS PLC Director/Miembro de la Junta 29/10/2015
ASTRAZENECA PLC Corporate Officer/Principal 01/04/2009
The Christie NHS Foundation Trust Corporate Officer/Principal -
Ver el detalle de la experiencia de Rajesh Chopra.

Formación de Rajesh Chopra.

University College London Doctorate Degree
The UCL Academy Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Rajesh Chopra.

Relaciones

100 +

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas2
E-THERAPEUTICS PLC

Health Technology

ASTRAZENECA PLC

Health Technology

Empresas privadas6

Health Technology

The Christie NHS Foundation Trust

Miscellaneous

Health Technology

Finance

Health Technology

Health Services

Ver las conexiones de la empresa